Among the moracin P derivative, only moracin P_4 was identified as a potential P-gp inhibitor, suggesting a potential for enhanced intracellular drug retention and reduced efflux-mediated resistance, which could be advantageous in cancer therapeutics. This evidence concerns the gene PGP and cancer.